Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
-491
% of shares
-0.26%
Amount (USD)
$1,919
Insider confidence score
45.0 out of 100
Positive
Negative
Security
Common Stock
Action
Exercise
Date
2026-03-02
Code
M
Net shares
+1,525.0
Acquired/Disposed
Acquired
Shares Owned Before
185,883.0
Shares Owned After
187,408.0
Security
Common Stock
Action
Tax_withhold
Date
2026-03-03
Code
F
Net shares
-491.0
Price per Share
$3.91
Amount (USD)
$1,919.81
Acquired/Disposed
Disposed
Shares Owned Before
187,408.0
Shares Owned After
186,917.0
Security
Restricted Stock Units
Action
Exercise
Date
2026-03-02
Code
M
Net shares
-1,525.0
Acquired/Disposed
Disposed
Shares Owned Before
3,050.0
Shares Owned After
1,525.0
1. Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
2. The award vested as to 25% of the restricted stock units on each of March 2, 2024, 2025 and 2026, and the remaining restricted stock units will vest on March 2, 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.